GSK PLC SPON ADS EACH REP 2 ORD SHS (GSK) - Price, trends, fundamentals and chart - Passport to Wall Street

GSK PLC SPON ADS EACH REP 2 ORD SHS (NYSE: GSK)

Overview

current price

$53.83

$53.83

change

0.44 | 0.81%

0.44 | 0.81%

Yesterday's Close

53.39

open

54.21

volume

3.41 M

30d. avg volume.

6.28 M

1 day

53.70 - 54.58

52 weeks

32.38 - 61.70

p/e

30.68

beta

0.3524

market cap

108.56 B

dividend yield

3.28%

Industry

-

News and Commentary

US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And... In a move that could impact vaccine-makers like Merck & Co. Inc.

CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans CVS Health Inc. (CVS&nb...

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth British pharmaceutical giant GSK Plc (

Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc.

FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $2... During market trading hours on Wednesday, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.'s

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch A Nevada dairy worker has screened positive for the D1.1 strain of bird flu associated with a Louisiana man's death in January, according to a CNN report. The Centers for Disease...

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The P... Global health concerns escalated Monday as the U.S. Centers for Disease Control and Prevention reportedly halted collaboration with the World Health Organization, coinciding with...

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine According to the latest data from the Centers for Disease Control and Prevention, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death as...

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...

StockTwits

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more